CPL-302415

N/A

Report date: 2025/01/26 16:22:05
NME

Base Information

Drug NameCPL-302415
Drug Alias NamePI3K delta inhibitor (Celon Pharma)CPL-302415
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsInflammationAutoimmune DiseasesLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelon Pharma SP
China Registration ClassN/A

Develop Information

Active CompaniesCelon Pharma SP
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A